Welcome Guest | Register / Login

Pharmaceuticals Market Research Reports

The global pharmaceutical market has persistently experienced significant growth due to the ever-increasing demand for novel and more effective drugs. The reasons for this steady increase in the demand for drugs worldwide can be attributed to population growth, newer and more complex disease conditions, ageing population, and the increased prevalence of chronic and infectious diseases, some of which still remain incurable and fatal. Such numerous unmet needs and high demand rates have triggered the boost in R&D investments by key industry sectors, greatly driving the growth of this i... View more

Sort By
Title Published Price Buy Now
Bahrain Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: Our outlook for Bahrain's pharmaceutical and healthcare sector remains strong, with the government announcing the development and expansion of health centres across the country in addition to several preventive health project...
Dec 2014 $ 1295
Bangladesh Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: Chronic diseases will become a key healthcare challenge for Bangladesh over the next decade. Driven by the country's ageing population, urbanisation and inadequate treatment of non-communicable diseases, this represents an ep...
Dec 2014 $ 1295
Belarus Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: The Belarusian market will suffer from the impact of depreciation and economic instability as the country's economy becomes ever more reliant on Russian loans to function. Furthermore, wage growth mandated by the government w...
Dec 2014 $ 1295
China Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: Improvements in intellectual property protection, an ageing population and increasing access to healthcare will drive the robust growth of China's pharmaceutical market. This will attract foreign drug manufacturers despite th...
Dec 2014 $ 1295
Finland Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: Finland, like many other Western countries, has a mature pharmaceutical market where growth is slowing. Although an ageing population will drive the demand for high-value medicines for the treatment of long-term illnesses, dr...
Dec 2014 $ 1295
India Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: The new government under Prime Minister Modi bodes well for the overall pharmaceutical sector. The proposed introduction of universal healthcare in 2015 coupled with small regulatory reform will help unlock the potential of t...
Dec 2014 $ 1295
Kazakhstan Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: Plans to boost government spending on healthcare will be positive for the pharmaceutical industry as well as other participants in the healthcare sector. Over the longer term, the introduction of compulsory health insurance w...
Dec 2014 $ 1295
Philippines Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: Our outlook for the Philippines' pharmaceutical sector remains bullish, driven by an increasing population and high burden of disease profile. Generic medicines will continue to account for an increasing share of pharmaceutic...
Dec 2014 $ 1295
United Kingdom Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: The pharmaceutical and healthcare markets of the United Kingdom are driven by government spending in the form of the National Health System (NHS), which accounts for over 80% of total healthcare spending. With a higher preval...
Dec 2014 $ 1295
Zimbabwe Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: The World Health Organization's approval of a quality control laboratory for medicines in Zimbabwe is a positive step for the country's pharmaceutical market. It will help to reduce the proportion of counterfeit medicines in ...
Dec 2014 $ 1295
United States Anesthesia Drugs Market & Forecast
By Renub Research
Renub Research report titled "United States Anesthesia Drugs Market & Forecast” provides a comprehensive analysis of the current state of this market and likely future evolution over the next 5 years. This 74 page report with 56 Figures ...
Dec 2014 $ 1450
Taiwan Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: Taiwan is one of the most attractive and stable prospects in the region for pharmaceutical and healthcare investment, but is not without flaws. Weaknesses in the country's regulatory regime and drug pricing concerns will continu...
Dec 2014 $ 1295
Switzerland Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: The Swiss government will need to develop policies to maintain the country's long-term attractiveness as a site for clinical trials, especially as we expect cost of conducting clinical research to rise. The drivers of increased ...
Dec 2014 $ 1295
Sudan Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: The already depreciating Sudanese pound will come under further strain should oil prices continue their decline as oil exports account for around 70% of total exports in the country. We are already forecasting short-term negativ...
Dec 2014 $ 1295
Saudi Arabia Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: We expect heavy investment into Saudi Arabia's healthcare sector to continue, particularly as the government sees the sector as key to the diversification of the economy. The medical tourism industry in particular provides oppor...
Dec 2014 $ 1295
Myanmar Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: Non-governmental organisations will continue to expand healthcare access in Myanmar - a boon for the country's pharmaceutical market. However, the country's poor protection of intellectual property, a weak healthcare system and ...
Dec 2014 $ 1295
Lebanon Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: The influx of Syrian refugees into Lebanon is putting a strain on the healthcare system, which is unable to meet the additional demand for treatment. Elevated political instability is putting the pharmaceutical sector at risk in...
Dec 2014 $ 1295
Iran Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: BMI continues to adjust its forecasts for Iran's pharmaceutical market to account for the sanction-induced currency crisis and high rates of inflation. The rapid depreciation of the rial means that we expect the value of the mar...
Dec 2014 $ 1295
France Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: Despite the French government partially abandoning fiscal deficit targets in its 2015 budget, cost-containment measures will continue to weigh on the pharmaceuticals and healthcare sector for the foreseeable future. The governme...
Dec 2014 $ 1295
Estonia Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: Despite growing in recent years, the absolute value of the Estonian pharmaceutical market remains small and will continue to remain a marginal market in the Central and Eastern European region. Low-cost generic drugs are prevale...
Dec 2014 $ 1295
Canada Pharmaceuticals and Healthcare Report Q1 2015
By Business Monitor International
BMI View: Canada's epidemiological profile will continue to be attractive to manufacturers of medicines for non-communicable diseases. Despite the relatively rapid uptake of innovative pharmaceuticals, the burden of chronic conditions wil...
Dec 2014 $ 1295
T - Bact-API Insights, 2014
By Delve Insight
Summary The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off ...
Dec 2014 $ 500
Telzir -API Insights, 2014
By Delve Insight
Summary The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off ...
Dec 2014 $ 500
Latuda-API Insights, 2014
By Delve Insight
Summary The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off ...
Dec 2014 $ 500
Selzentry-API Insights, 2014
By Delve Insight
Summary The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off ...
Dec 2014 $ 500
Live Chat
Live Chat by Comm100